Company Filing History:
1 out of 1 
1 out of 21 
1 out of 30 Years Active: 2019-2023
Title: The Innovations of Inventor Daniel Olal in Plasma Cell Disease Treatments
Introduction
Daniel Olal is a remarkable inventor based in Berlin, Germany, who has made significant contributions to the field of medical research. With a total of three patents to his name, his work focuses on innovative treatments for plasma cell diseases, including multiple myeloma and autoimmune disorders. His cutting-edge research not only addresses critical medical challenges but also opens up new avenues for therapeutic interventions.
Latest Patents
Daniel Olal's latest patents showcase his expertise in developing antibodies that target CD269 (BCMA), a key player in plasma cell-mediated diseases. One of his notable inventions involves a composition comprising a cell or a population thereof, where the cell contains a polynucleotide encoding an antibody or its fragment that binds CD269 (BCMA). This binding disrupts the interaction between CD269 and its native ligands, BAFF and APRIL, facilitating potential treatment strategies for diseases like multiple myeloma. His innovative approach also includes antibodies or fragments that bind CD269 (BCMA), with the aim of intervening in the disease pathways linked to plasma cell disorders.
Career Highlights
Throughout his career, Daniel Olal has worked in esteemed institutions, including the Max-Delbrück-Centrum für Molekulare Medizin. His research at these institutions has played a crucial role in advancing the understanding of plasma cell diseases and identifying new treatment modalities. Olal's work is characterized by a blend of scientific rigor and innovative thinking, contributing significantly to the medical field.
Collaborations
Daniel has had the opportunity to collaborate with notable professionals in his field, including Martin Lipp and Felix Oden. These collaborations have enriched his research endeavors and fostered a collaborative environment that drives innovation in medical treatments for complex diseases.
Conclusion
In summary, Daniel Olal stands out as a dedicated inventor whose work has the potential to transform the landscape of treatments for plasma cell diseases. His innovative patents targeting CD269 (BCMA) highlight the importance of his contributions to medical research. As he continues to explore new frontiers in medicine, the impact of his inventions will undoubtedly be felt in the ongoing battle against multiple myeloma and autoimmune disorders.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.